Urgent recall for vitamin gummies over 'life-threatening health risk'
Vita Warehouse Corp is recalling a lot of its Welby brand Vitamin B12 Energy Support gummy product 1000 mcg gummies, Berkely Jensen Vitamin B12 1000 mcg Gummies, and VitaGlobe Vitamin B12 Extra Strength Gummies.
'People with an allergy or severe sensitivity to peanuts run the potential risk of serious or life-threatening allergic reactions if they consume these products,' states an advisory published by the US Food and Drug Administration (FDA) on Friday.
The Webly vitamins came with 140 gummies in a clear bottle with a white cap and a green, red and white label. They have an expiration date of October 2026, the UPC code 4099100290868 and the lot number 248046601 printed at the bottom.
Berkley Jensen vitamins under the recall came with 250 gummies in a clear bottle with a white cap and red and pink labels. They have an expiration date of October 2026, the UPC code 888670132487 and the lot number 248046601.
The VitaGlobe vitamins came with 60 gummies in a clear bottle with a white cap and green, red and white labels. They have the same expiration date as the other two brands, the UPC code 850005214670 and the lot number 248046601.
They were sent to ALDI and BJ's stores nationwide.
There have not been any allergic reactions or illnesses linked to the vitamins that have been reported. More Trending
Anyone who experiences an allergic reaction should see a doctor right away.
Customers who are allergic to peanuts should throw them away immediately or return them for a full refund.
'Vita Warehouse Corp is committed to maintaining the highest product safety and quality standards,' states the FDA notice.
It comes a week after Aldi recalled its Casa Mamita Churro Bites Filled with Chocolate Hazelnut Cream because they were found to have an undeclared allergen, milk, that could cause 'a serious or life-threatening allergic reaction'.
Get in touch with our news team by emailing us at webnews@metro.co.uk.
For more stories like this, check our news page.
MORE: Man 'urinates on $10,000 worth of Spam and sausages forcing them to be tossed'
MORE: Everything to know about Donald Trump's military parade on his 79th birthday
MORE: Lawmaker forcefully removed from Trump secretary's LA protests conference and handcuffed
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
2 hours ago
- Reuters
US Senate to vote on Trump funding cuts, AIDS program funding preserved
WASHINGTON, July 15 (Reuters) - The U.S. Senate is due to begin voting on Tuesday on President Donald Trump's request to slash billions in spending on foreign aid and public broadcasting previously approved by Congress, the latest test of Trump's control over his fellow Republicans. However, Office of Management and Budget Director Russell Vought told reporters it will no longer include a plan to cut funds designated for PEPFAR, a global fund to fight HIV/AIDS, bringing the size of the package of cuts to $9 billion from $9.4 billion. Senator John Thune of South Dakota, the chamber's Republican majority leader, said he expected the first procedural voting on Tuesday. He had said that some members of his party had wanted changes in the bill. The Senate has until Friday to act on the rescissions package, originally a request to claw back $8.3 billion in foreign aid funding and $1.1 billion for public broadcasting. Otherwise, the request will expire and the White House will be required to adhere to spending plans passed by Congress. Approving the Senate bill without the PEPFAR cuts means the measure must go back to the House of Representatives for a vote before it can be sent back to Trump to sign into law. Thune said he expected the House would act quickly to pass the measure. The amounts at stake are extremely small in the context of the sprawling federal budget, which totaled $6.8 trillion in the fiscal year ended September 30. Yet the proposed cuts have raised the hackles of Democrats and a handful of Republicans who saw an attempt to erode Congress's Constitutionally mandated authority over spending. The foreign aid initiatives in Trump's request for cuts included lifesaving support for women and children's health and the fight against HIV/AIDS that have long had strong bipartisan support. The package also cuts funds supporting public broadcasting, which can be the main source of news and emergency information in rural parts of the U.S. Critics of the cuts said the amounts of money involved were small but funded essential programs that should not be cut. "What is going on here? Does anyone stand up to these horrible, horrible cuts that hurt the American people?" Senator Charles Schumer of New York, the chamber's Democratic leader, said on Monday. Trump has threatened to withhold his endorsement from any member of Congress who does not vote for the measure without changes. Standalone presidential rescissions packages have not passed in years, with lawmakers reluctant to cede their constitutionally mandated control of government spending. During Trump's first term in 2018, Congress members rejected Trump's request to revoke $15 billion in spending. Trump's Republicans hold narrow majorities in the Senate and House. So far, they have shown little appetite for opposing his policies. The rescissions legislation passed the House by 214-212 last month. Four Republicans joined 208 Democrats in voting against it. Some Republican senators had expressed concern about some of Trump's requests. Senator Susan Collins of Maine, who chairs the Appropriations Committee, had said she opposed Trump's request to cut funding for the global programs to fight HIV/AIDS. Democrats have warned that the foreign aid and broadcasting cuts, which overturn spending agreements between Republicans and Democrats, could make it more difficult to negotiate the package of spending bills that must pass by September 30 to fund the government next year and avoid a shutdown. "How are we supposed to negotiate a bipartisan deal if Republicans will turn around and put it through the shredder in a partisan vote?" asked Senator Patty Murray from Washington, the top Democrat on the appropriations committee. Appropriations bills require 60 votes to move ahead in the Senate, but the rescissions package needs just 51, meaning Republicans can pass it without Democratic support.
Daily Mail
3 hours ago
- Daily Mail
Urgent recall for popular yogurt brand over fears it contains shards of PLASTIC that could slice throats
Thousands of popular yogurt cups are being taken off shelves nationwide over fears they could contain one-inch shards of sharp plastic. All 17 flavors and sizes of YoCrunch, made by Danone, with toppings including granola, cookie dough, Oreo, M&M, Snickers and Twix pieces are being recalled. The Food and Drug Administration (FDA) found the plastic shards in the toppers that contain toppings and warned that they could pose a choking hazard or worse, slice a consumer's throat. The pieces are described as transparent, potentially with sharp edges, and between 0.2 and one-inch in size, or up to the size of a quarter. Several customers have contacted the FDA to report the plastic pieces, although no injuries or hospitalizations have been reported to date. Danone said the recall affected all its YoCrunch products on shelves, which were manufactured between May and early June and have a sell-by date of September this year. The company issued the recall on July 11, noting products were sold in many major retail chains, including Walmart, Target, Dollar General and Wegmans. Customers who have the products in refrigerators at home are advised not to consume them and to throw them out. They can contact the YoCrunch team for a refund. Consumers who suspect injury after consumption are urged to seek immediate medical care. In the release warning of the plastic pieces, the FDA said: 'These fragments pose a potential choking hazard, which is why we are taking immediate action to remove all affected products from store shelves.' Danone has said that a packaging error has led to the recall, after the plastics found in the topping pots were found to match the material used to mold the packaging. YoCrunch yogurts are heat-sealed at facilities in White Plains, New York, and Louisville, Colorado, the release said. The company's recall notice advises consumers to carefully check lot codes and expiration dates on YoCrunch products and contact their customer service hotline at 1-877-344-4886 for refunds or replacements. Customers can access a full list of the products involved in the recall on the FDA's website. It includes 6oz yogurt pots of strawberry and vanilla flavored yogurts with toppings including granola, M&Ms, Oreos and Snickers. And four packs of 4oz yogurts with a variety of toppings. Revealing the recall, the FDA classified it as Class II, its second highest risk level and meaning the product could cause temporary or reversible health consequences such as injury. And the side of a package of YoCrunch yogurts that are involved in the recall Although the plastic was limited to the toppers, the company opted to recall all variations of the product. The company said: 'Our top priority is ensuring the safety and quality of our products before they return to store shelves.' Danone North America, the parent company behind both the International Delight coffee creamer and YoCrunch yogurt brands, has faced multiple product recalls in recent months. Earlier this year, Danone voluntarily recalled more than 75,000 bottles of International Delight coffee creamers due to consumer reports of spoilage and illness. It also marked the third major recall this month involving a dangerous foreign object in packaged food. In June, Totally Cool Inc recalled over two dozen ice cream products, sold under brands like Friendly's, Hershey's, and Chipwich, after plastic and metal fragments were discovered inside the tubs. In another incident in May, a recall of packaged salads was announced by Fresh Farms Inc after metal fragments were found in some of their products. Industry observers say that the recent surge in recalls reflects pandemic-era supply chain challenges and the rapid adoption of automation, sometimes outpacing quality control improvements. A June 2025 report from the Institute of Food Technologists found a 15 percent increase in reported incidents involving plastic fragments in processed foods over the past three years, often linked to packaging equipment malfunctions or material defects. According to the Centers for Disease Control and Prevention (CDC), nearly one in six Americans contract a foodborne illness each year, resulting in about 128,000 hospitalizations and 3,000 deaths.
Daily Record
7 hours ago
- Daily Record
Scientists make Parkinson's breakthrough with new weekly injectable drug
Scientists have developed a new weekly injectable drug that could transform the lives of more than eight million people living with Parkinson's disease. The new treatment, which helps with muscle tremors, could potentially replace the need for multiple daily tablets, making life simpler and easier for those living with the condition. Scientists from the University of South Australia (UniSA) developed a long-acting injectable formulation that delivers a steady dose of levodopa and carbidopa - two key medications for Parkinson's - to last an entire week. The medication comes in the form of a biodegradable gel that can be injected under the skin or into muscle tissue, where it gradually releases the drugs over a week-long period. Parkinson's disease is the second most common neurological disorder, affecting more than 8.5 million people worldwide. There are approximately 13,000 people living with Parkinson's disease in Scotland, according to Parkinson's UK. Currently there is no cure, and the many symptoms of the condition, including tremors, rigidity and slow movement, are currently managed with pills that must be taken several times a day. But scientists believe the newly developed injection for Parkinson's could revolutionise how the disease is treated, and change the lives of those living with the condition. Lead researcher Professor Sanjay Garg, from UniSA's Centre for Pharmaceutical Innovation, said: "Our goal was to create a formulation that simplifies treatment, improves patient compliance, and maintains consistent therapeutic levels of medication. "This weekly injection could be a game-changer for Parkinson's care. Levodopa is the gold-standard therapy for Parkinson's, but its short life span means it must be taken several times a day." But the new drug can stop the constant hassle of taking multiple pills every day. The jab can maintain consistent plasma levels in the body by slowly releasing both levodopa and carbidopa steadily throughout the week, which also reduces the risks associated with fluctuating drug concentrations. UniSA PhD student Deepa Nakmode said: "After years of focused research, it's incredibly rewarding to see our innovation in long-acting injectables for Parkinson's disease reach this stage. Our invention has now been filed for an Australian patent." The injectable gel combines an FDA-approved biodegradable polymer named PLGA with Eudragit L-100, which is a pH-sensitive polymer. This ensures a controlled and sustained drug release into the body. Prof Garg concluded: "The implications of this research are profound. By reducing the frequency of dosing from multiple times a day to a weekly injection is a major step forward in Parkinson's therapy. "We're not just improving how the drug is delivered; we're improving patients' lives." The scientist says this new technology could also be adapted for other chronic conditions such as cancer, diabetes, neurodegenerative disorders, pain management, and chronic infections.
